Cigna Group
Income Statement
| Line Item | FY2009 | FY2008 | FY2007 | FY2006 |
|---|---|---|---|---|
| Revenue | $18.41B | $19.10B | $17.63B | $16.55B |
| Pharmacy Revenues | $1.94B | $1.85B | $1.51B | $1.33B |
| Premiums | $13.29B | $13.88B | $12.85B | $12.06B |
| Fees and Other Revenues | $2.14B | $2.17B | $2.04B | $1.83B |
| Net Investment Income | $1.12B | $1.20B | $1.21B | $1.22B |
| Realized Investment Gains (Losses) | $-82.0M | $-288.0M | $18.0M | $107.0M |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Operating Margin | — | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | — | — | — | — |
| Net Income | — | — | — | — |
| Net Margin | — | — | — | — |
| EPS (Basic) | — | — | — | — |
| EPS (Diluted) | — | — | — | — |
| Shares Outstanding (Basic) | — | — | — | — |
| Shares Outstanding (Diluted) | — | — | — | — |
| Dividends Per Share | — | — | — | — |